RxSight, Inc. (RXST)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Ronald M. Kurtz M.D. | President, CEO & Director | 1.21M | -- | 1963 |
| Mr. Eric J. Weinberg | Co-President & Chief Commercial Officer | 762.74k | -- | 1961 |
| Ms. Shelley B. Thunen | Co-President & Chief Financial Officer | 762.22k | -- | 1954 |
| Dr. Ilya Goldshleger Ph.D. | Co-President & Chief Operating Officer | 761.46k | -- | 1975 |
| Ms. Rebecca Williston | Vice President of Accounting & Finance | -- | -- | -- |
| Mr. Matt Haller Ph.D. | Chief Technology Officer | -- | -- | -- |
| Mr. Oliver Moravcevic | Vice President of Investor Relations | -- | -- | -- |
| Mr. Steve Everly | Senior VP of Sales of North America | -- | -- | -- |
| Mr. Roy Freeman | Senior VP of Marketing & Professional Relations | -- | -- | -- |
| Ms. Caroline Vaughn | Vice President of Human Resources | -- | -- | -- |
RxSight, Inc.
- Sector:?
- Healthcare
- Industry:? Medical Devices
- Full Time Employees:?
- 374
Description
RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Corporate Governance
Upcoming Events
November 7, 2024 at 9:00 PM UTC
RxSight, Inc. Earnings Date
Recent Events
May 16, 2024 at 12:00 AM UTC
SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)